IQMD SEC filings, in plain English

• SC 13G14 February 20240001104659-24-022617
• 15-12G12 May 20230001104659-23-059809
• 25-NSE2 May 20230001354457-23-000333
• 327 April 20230001209191-23-025910
• 8-K26 April 20230001104659-23-049966
• 10-K17 April 20230001104659-23-046201
  What changed vs 2022-03-30trust $211.1M → $213.8M +1%deadline 2023-02-09 → 2023-09-09
  trust account, combination deadline, going-concern doubt +22 moved · 3 with no prior record of ours

  Trust account

  $211.1M→$213.8M

  SpacBrain reads this as $2,703,526 was added to the trust between the two filings.

  The clause “28 ​ 157,975 Total Current Assets ​ ​ 187,580 ​ ​ 747,250 ​ ​ ​ ​ ​ Investments held in the Trust Account ​ ​ 213,846,754 ​ ​ 211,143,228 ​ ​ ​ ​ ​ ​ ​ Other assets ​ ​ — ​ ​ 103,970 Total Assets ​ $ 214,034,334 ​ $ 211,994,448 ​ ​ ​ ​ ​”…

  Combination deadline

  2023-02-09→2023-09-09

  SpacBrain reads this as 212 days later than the previous record.

  The clause “350,000 deferred underwriting fees were contingent upon the consummation of the Business Combination by September 9, 2023; however, on February 7, 2023, the Company and the underwriter entered into a Fee Reduction Agreement, pursuant to”…

  Going-concern doubt

  stated · unchanged

  The clause …“the DGCL. Our financial statement footnotes include disclosure regarding the substantial doubt about our ability to continue as a “going concern.” We have incurred and expect to continue to incur significant costs in pursuit of our”…

  Mandate language

  we intend to focus our search on life science companies that… · unchanged

  Redeemable shares

  20.7M · unchanged

  The clause …“value, 200,000,000 shares authorized, none issued and outstanding (excluding 20,700,000 shares subject to possible redemption) ​ — ​ — Class B common stock, $ 0.0001 par value, 20,000,000 shares authorized, 5,175,000 shares issued and”…

  Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

• SC 13G/A13 April 20230001062993-23-009089
• 8-K7 April 20230001104659-23-043149
• 8-K5 April 20230001104659-23-042169
• NT 10-K3 April 20230001104659-23-040748
• 428 February 20230001510281-23-000025
• 8-K23 February 20230001104659-23-024376
• 42523 February 20230001104659-23-024379
• SC 13D21 February 20230001104659-23-023806
• 410 February 20230001104659-23-018561
• 8-K9 February 20230001104659-23-017381
• 8-K3 February 20230001104659-23-010616
• DEFA14A3 February 20230001104659-23-010625
• DEFA14A27 January 20230001104659-23-007268
• DEF 14A19 January 20230001104659-23-005025

  What changed: Intelligent Medicine Acquisition Corp. called a completely virtual special meeting for February 3, 2023 at 9:30 AM Eastern to extend the combination period seven months, from February 9, 2023, fifteen months after the IPO closing, to September 9, 2023. The sole extension payment is a deposit of 200,000 shares of the company's Class B common stock into the trust account, contributed by the sponsor; no cash deposit is provided for. The board states it is in discussions regarding a business combination. Redemption requires tender to the transfer agent by February 1, 2023. Why it matters: An extension funded entirely with founder shares and no cash means the trust receives nothing that can be converted to a dependable per-share value, so the redemption floor does not grow at all across seven months of waiting. Class B shares of a SPAC without a completed deal have no market and are worthless in a liquidation, so the consideration for the delay is effectively zero. Against an unnamed target still only in discussions, redeeming at pro rata trust value by the February 1 deadline is the option with a defined outcome.

• UPLOAD18 January 20230000000000-23-000533
• CORRESP17 January 20230001104659-23-004227
• UPLOAD17 January 20230000000000-23-000425
• PRE 14A4 January 20230001104659-23-000869
• 10-Q14 November 20220001104659-22-118572
  What changed vs 2022-08-15trust $211.4M → $212.4M +0%
  trust account, combination deadline, going-concern doubt +11 moved · 3 with no prior record of ours

  Trust account

  $211.4M→$212.4M

  SpacBrain reads this as $953,013 was added to the trust between the two filings.

  The clause “157,975 Total Current Assets ​ ​ 307,501 ​ ​ 747,250 ​ ​ ​ ​ ​ ​ ​ Investments held in the Trust Account ​ ​ 212,402,618 ​ ​ 211,143,228 ​ ​ ​ ​ ​ ​ ​ Other assets ​ ​ 14,071 ​ ​ 103,970 Total Assets ​ $ 212,724,190 ​ $ 211,994,448 ​ ​ ​”…

  Combination deadline

  2023-02-09 · unchanged

  The clause …“deferred underwriting fees are contingent upon the consummation of the Business Combination by February 9, 2023. Following the closing of the Initial Public Offering on November 9, 2021, an amount of $211,140,000 ($10.20 per”…

  Going-concern doubt

  stated · unchanged

  The clause …“to liquidate and dissolve. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “ Disclosures of Uncertainties about an Entity’s Ability to”…

  Redeemable shares

  20.7M · unchanged

  The clause …“value, 200,000,000 shares authorized, none issued and outstanding (excluding 20,700,000 shares subject to possible redemption) ​ ​ — ​ ​ — Class B common stock, $ 0.0001 par value, 20,000,000 shares authorized, 5,175,000 shares issued”…

  Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

• 10-Q15 August 20220001104659-22-091384
  What changed vs 2022-05-17trust $211.2M → $211.4M +0%
  trust account, combination deadline, going-concern doubt +11 moved · 3 with no prior record of ours

  Trust account

  $211.2M→$211.4M

  SpacBrain reads this as $285,115 was added to the trust between the two filings.

  The clause “157,975 Total Current Assets ​ ​ 424,812 ​ ​ 747,250 ​ ​ ​ ​ ​ ​ ​ Investments held in the Trust Account ​ ​ 211,449,605 ​ ​ 211,143,228 ​ ​ ​ ​ ​ ​ ​ Other assets ​ ​ 45,903 ​ ​ 103,970 Total Assets ​ $ 211,920,320 ​ $ 211,994,448 ​ ​ ​”…

  Combination deadline

  2023-02-09 · unchanged

  The clause …“deferred underwriting fees are contingent upon the consummation of the Business Combination by February 9, 2023. Following the closing of the Initial Public Offering on November 9, 2021, an amount of $211,140,000 ($10.20 per”…

  Going-concern doubt

  stated · unchanged

  The clause …“to liquidate and dissolve. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “ Disclosures of Uncertainties about an Entity’s Ability to”…

  Redeemable shares

  20.7M · unchanged

  The clause …“value, 200,000,000 shares authorized, none issued and outstanding (excluding 20,700,000 shares subject to possible redemption) ​ ​ — ​ ​ — Class B common stock, $ 0.0001 par value, 20,000,000 shares authorized, 5,175,000 shares issued”…

  Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

• 3/A7 June 20220001510281-22-000121
• 10-Q17 May 20220001104659-22-062088
  trust account, combination deadline, redeemable shares +2nothing moved · 5 with no prior record of ours

  Trust account

  not previously extracted→$211.2M

  The clause “157,975 Total Current Assets ​ ​ 594,251 ​ ​ 747,250 ​ ​ ​ ​ ​ ​ ​ Investments held in the Trust Account ​ ​ 211,164,490 ​ ​ 211,143,228 ​ ​ ​ ​ ​ ​ ​ Other assets ​ ​ 77,043 ​ ​ 103,970 Total Assets ​ $ 211,835,784 ​ $ 211,994,448 ​ ​ ​”…

  Combination deadline

  not previously extracted→2023-02-09

  The clause …“deferred underwriting fees are contingent upon the consummation of the Business Combination by February 9, 2023. Following the closing of the Initial Public Offering on November 9, 2021, an amount of $211,140,000 ($10.20 per”…

  Redeemable shares

  not previously extracted→20.7M

  The clause …“value, 200,000,000 shares authorized, none issued and outstanding (excluding 20,700,000 shares subject to possible redemption) ​ ​ — ​ ​ — Class B common stock, $ 0.0001 par value, 20,000,000 shares authorized, 5,175,000 shares issued”…

  Going-concern doubt

  stated · unchanged

  The clause …“to liquidate and dissolve. In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “ Disclosures of Uncertainties about an Entity's Ability to”…

  Sponsor loans outstanding

  $165K→not matched in this filing

  Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

• NT 10-Q17 May 20220001104659-22-061829
• 39 May 20220001510281-22-000094
• SC 13G/A9 May 20220001062993-22-011872
• 10-K30 March 20220001104659-22-039834
• SC 13G/A14 February 20220001193125-22-037833
• SC 13G/A14 February 20220001062993-22-003970
• SC 13G11 February 20220001104659-22-020161
• SC 13G8 February 20220001104659-22-013388
• SC 13G/A27 January 20220000902664-22-000637
• 8-K23 December 20210001104659-21-153128
• 10-Q20 December 20210001104659-21-151742
• SC 13G19 November 20210000902664-21-005060

The complete IQMD filing history on EDGAR